GlassScriptPhysician profile
Alexander M Culbreth
NPI 1447336185
$6,194.25
in general payments reported to CMS, 2019-2025
53 companies · $876 in 2025
The $876 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,275 · 2020: $536 · 2021: $647 · 2022: $996 · 2023: $924 · 2024: $940 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,679 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,678.90 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,040.85 | 2019-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $650.44 | 2019-2025 | |
| Abbvie INC. | $645.93 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Amgen INC. | $555.27 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $384.29 | 2019-2024 | |
| Shield Therapeutics INC | $330.40 | 2023-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $240.74 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $180.05 | 2024-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $166.04 | 2022-2024 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Evofem Biosciences, INC. | $152.30 | 2020-2023 | Phexxi |
| Mayne Pharma Commercial LLC | $104.59 | 2024-2025 | |
| Organon LLC | $103.59 | 2022-2024 | Nexplanon |
| Novo Nordisk INC | $101.32 | 2019-2025 | Wegovy |
| Avion Pharmaceuticals | $93.38 | 2019-2023 | Balcoltra |
| Pacira Pharmaceuticals Incorporated | $92.33 | 2020-2025 | Exparel |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $79.92 | 2019-2022 | |
| Coloplast Corp | $77.50 | 2019-2022 | |
| Baxter Healthcare | $67.67 | 2022-2023 | Perclot |
| Millicent US INC | $66.60 | 2020-2025 | Femring, Intrarosa, Femlyv |
| Caldera Medical, INC | $64.63 | 2022 | |
| Daiichi Sankyo INC. | $63.16 | 2019-2022 | |
| Myriad Women'S Health, INC. | $59.47 | 2023 | Myrisk |
| Optumhealth Care Solutions, LLC | $54.59 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Biohaven Pharmaceuticals, INC. | $54.12 | 2021 | |
| Davol INC. | $53.35 | 2020-2024 | Arista Ah Flexitip |
| Sage Therapeutics, LLC | $51.39 | 2024-2025 | Zurzuvae |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.26 | 2022-2023 | Trulance, Xifaxan |
| Lilly USA, LLC | $48.87 | 2024-2025 | Zepbound |
| Cepheid | $45.30 | 2025 | Genexpert |
| Duchesnay USA Incorporated | $38.16 | 2019 | |
| Merck Sharp & Dohme LLC | $38.15 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $34.05 | 2019-2020 | |
| Exact Sciences Corporation | $33.22 | 2023-2024 | Cologuard Collection Kit |
| Monaghan Medical Corporation | $31.78 | 2024 | Aerochamber |
| Aspira Women'S Health INC | $28.69 | 2024 | Ova1 |
| Lsi Solutions INC | $25.43 | 2023 | Fornisee |
| Radius Health, INC. | $24.75 | 2024 | Tymlos |
| Northgate Technologies, INC. | $23.44 | 2024 | Stimsite |
| Sanofi Pasteur INC. | $22.79 | 2025 | |
| Axonics, INC. | $21.82 | 2023 | Axonics |
| Roche Diagnostics Corporation | $20.17 | 2019 | |
| Mimedx Group, INC. | $19.26 | 2024 | |
| Bausch Health US, LLC | $18.86 | 2024 | Aplenzin, Wellbutrin |
| Channel Medsystems, INC. | $16.56 | 2024 | |
| Lupin INC. | $15.00 | 2019 | |
| Exeltis, USA INC. | $14.66 | 2024 | Slynd |
| Allergan, INC. | $14.31 | 2019 | |
| Agile Therapeutics, INC. | $13.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.56 | 2022 | |
| Olympus America INC. | $13.50 | 2019 | |
| Coopersurgical, INC. | $12.88 | 2019 | |
| Dysis Medical, INC. | $11.46 | 2020 | |
| Meditrina | $9.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Culbreth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.